Photo
 
The Department of Health today (July 2) endorsed the recall of one batch of Thymoglobuline for IV Injection 25mg/5ml (Registration number: HK-33039) from the market by a licensed drug wholesaler, Sanofi-Aventis Hong Kong Limited, because of a stability issue.
 
Close